Literature DB >> 31820065

Diffusion tensor imaging radiomics in lower-grade glioma: improving subtyping of isocitrate dehydrogenase mutation status.

Chae Jung Park1, Yoon Seong Choi2, Yae Won Park3, Sung Soo Ahn1, Seok-Gu Kang4, Jong-Hee Chang4, Se Hoon Kim5, Seung-Koo Lee1.   

Abstract

PURPOSE: To evaluate whether diffusion tensor imaging (DTI) radiomics with machine learning improves the prediction of isocitrate dehydrogenase (IDH) mutation status of lower-grade gliomas beyond radiomic features from conventional MRI and DTI histogram parameters.
METHODS: A total of 168 patients with pathologically confirmed lower-grade gliomas were retrospectively enrolled. A total of 158 and 253 radiomic features were extracted from DTI (DTI radiomics) and conventional MRI (T1-weighted image with contrast enhancement, T2-weighted image, and FLAIR [conventional radiomics]), respectively. The random forest models for predicting IDH status were trained with variable combinations as follows: (1) DTI radiomics, (2) conventional radiomics, (3) conventional radiomics + DTI radiomics, and (4) conventional radiomics + DTI histogram. The models were validated with nested cross-validation. The predictive performances of those models were compared by using area under the curve (AUC) from receiver operating characteristic analysis, and 95% confidence interval (CI) was calculated.
RESULTS: Adding DTI radiomics to conventional radiomics significantly improved the accuracy of IDH status subtyping (AUC, 0.900 [95% CI, 0.855-0.945], p = 0.006), whereas adding DTI histogram parameters yielded nonsignificant trend toward improvement (0.869 [95% CI, 0.816-0.922], p = 0.150) compared with the model with conventional radiomics alone (0.835 [95% CI, 0.773-0.896]). The performance of the model consisting of both DTI and conventional radiomics was significantly superior than that of model consisting of both DTI histogram parameters and conventional radiomics (0.900 vs 0.869, p = 0.040).
CONCLUSION: DTI radiomics with machine learning can help improve the subtyping of IDH status beyond conventional radiomics and DTI histogram parameters in patients with lower-grade gliomas.

Entities:  

Keywords:  Diffusion tensor imaging; Isocitrate dehydrogenase; Lower-grade glioma; Machine learning; Radiomics

Mesh:

Substances:

Year:  2019        PMID: 31820065     DOI: 10.1007/s00234-019-02312-y

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  42 in total

1.  Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

Authors:  Daniel J Brat; Roel G W Verhaak; Kenneth D Aldape; W K Alfred Yung; Sofie R Salama; Lee A D Cooper; Esther Rheinbay; C Ryan Miller; Mark Vitucci; Olena Morozova; A Gordon Robertson; Houtan Noushmehr; Peter W Laird; Andrew D Cherniack; Rehan Akbani; Jason T Huse; Giovanni Ciriello; Laila M Poisson; Jill S Barnholtz-Sloan; Mitchel S Berger; Cameron Brennan; Rivka R Colen; Howard Colman; Adam E Flanders; Caterina Giannini; Mia Grifford; Antonio Iavarone; Rajan Jain; Isaac Joseph; Jaegil Kim; Katayoon Kasaian; Tom Mikkelsen; Bradley A Murray; Brian Patrick O'Neill; Lior Pachter; Donald W Parsons; Carrie Sougnez; Erik P Sulman; Scott R Vandenberg; Erwin G Van Meir; Andreas von Deimling; Hailei Zhang; Daniel Crain; Kevin Lau; David Mallery; Scott Morris; Joseph Paulauskis; Robert Penny; Troy Shelton; Mark Sherman; Peggy Yena; Aaron Black; Jay Bowen; Katie Dicostanzo; Julie Gastier-Foster; Kristen M Leraas; Tara M Lichtenberg; Christopher R Pierson; Nilsa C Ramirez; Cynthia Taylor; Stephanie Weaver; Lisa Wise; Erik Zmuda; Tanja Davidsen; John A Demchok; Greg Eley; Martin L Ferguson; Carolyn M Hutter; Kenna R Mills Shaw; Bradley A Ozenberger; Margi Sheth; Heidi J Sofia; Roy Tarnuzzer; Zhining Wang; Liming Yang; Jean Claude Zenklusen; Brenda Ayala; Julien Baboud; Sudha Chudamani; Mark A Jensen; Jia Liu; Todd Pihl; Rohini Raman; Yunhu Wan; Ye Wu; Adrian Ally; J Todd Auman; Miruna Balasundaram; Saianand Balu; Stephen B Baylin; Rameen Beroukhim; Moiz S Bootwalla; Reanne Bowlby; Christopher A Bristow; Denise Brooks; Yaron Butterfield; Rebecca Carlsen; Scott Carter; Lynda Chin; Andy Chu; Eric Chuah; Kristian Cibulskis; Amanda Clarke; Simon G Coetzee; Noreen Dhalla; Tim Fennell; Sheila Fisher; Stacey Gabriel; Gad Getz; Richard Gibbs; Ranabir Guin; Angela Hadjipanayis; D Neil Hayes; Toshinori Hinoue; Katherine Hoadley; Robert A Holt; Alan P Hoyle; Stuart R Jefferys; Steven Jones; Corbin D Jones; Raju Kucherlapati; Phillip H Lai; Eric Lander; Semin Lee; Lee Lichtenstein; Yussanne Ma; Dennis T Maglinte; Harshad S Mahadeshwar; Marco A Marra; Michael Mayo; Shaowu Meng; Matthew L Meyerson; Piotr A Mieczkowski; Richard A Moore; Lisle E Mose; Andrew J Mungall; Angeliki Pantazi; Michael Parfenov; Peter J Park; Joel S Parker; Charles M Perou; Alexei Protopopov; Xiaojia Ren; Jeffrey Roach; Thaís S Sabedot; Jacqueline Schein; Steven E Schumacher; Jonathan G Seidman; Sahil Seth; Hui Shen; Janae V Simons; Payal Sipahimalani; Matthew G Soloway; Xingzhi Song; Huandong Sun; Barbara Tabak; Angela Tam; Donghui Tan; Jiabin Tang; Nina Thiessen; Timothy Triche; David J Van Den Berg; Umadevi Veluvolu; Scot Waring; Daniel J Weisenberger; Matthew D Wilkerson; Tina Wong; Junyuan Wu; Liu Xi; Andrew W Xu; Lixing Yang; Travis I Zack; Jianhua Zhang; B Arman Aksoy; Harindra Arachchi; Chris Benz; Brady Bernard; Daniel Carlin; Juok Cho; Daniel DiCara; Scott Frazer; Gregory N Fuller; JianJiong Gao; Nils Gehlenborg; David Haussler; David I Heiman; Lisa Iype; Anders Jacobsen; Zhenlin Ju; Sol Katzman; Hoon Kim; Theo Knijnenburg; Richard Bailey Kreisberg; Michael S Lawrence; William Lee; Kalle Leinonen; Pei Lin; Shiyun Ling; Wenbin Liu; Yingchun Liu; Yuexin Liu; Yiling Lu; Gordon Mills; Sam Ng; Michael S Noble; Evan Paull; Arvind Rao; Sheila Reynolds; Gordon Saksena; Zack Sanborn; Chris Sander; Nikolaus Schultz; Yasin Senbabaoglu; Ronglai Shen; Ilya Shmulevich; Rileen Sinha; Josh Stuart; S Onur Sumer; Yichao Sun; Natalie Tasman; Barry S Taylor; Doug Voet; Nils Weinhold; John N Weinstein; Da Yang; Kosuke Yoshihara; Siyuan Zheng; Wei Zhang; Lihua Zou; Ty Abel; Sara Sadeghi; Mark L Cohen; Jenny Eschbacher; Eyas M Hattab; Aditya Raghunathan; Matthew J Schniederjan; Dina Aziz; Gene Barnett; Wendi Barrett; Darell D Bigner; Lori Boice; Cathy Brewer; Chiara Calatozzolo; Benito Campos; Carlos Gilberto Carlotti; Timothy A Chan; Lucia Cuppini; Erin Curley; Stefania Cuzzubbo; Karen Devine; Francesco DiMeco; Rebecca Duell; J Bradley Elder; Ashley Fehrenbach; Gaetano Finocchiaro; William Friedman; Jordonna Fulop; Johanna Gardner; Beth Hermes; Christel Herold-Mende; Christine Jungk; Ady Kendler; Norman L Lehman; Eric Lipp; Ouida Liu; Randy Mandt; Mary McGraw; Roger Mclendon; Christopher McPherson; Luciano Neder; Phuong Nguyen; Ardene Noss; Raffaele Nunziata; Quinn T Ostrom; Cheryl Palmer; Alessandro Perin; Bianca Pollo; Alexander Potapov; Olga Potapova; W Kimryn Rathmell; Daniil Rotin; Lisa Scarpace; Cathy Schilero; Kelly Senecal; Kristen Shimmel; Vsevolod Shurkhay; Suzanne Sifri; Rosy Singh; Andrew E Sloan; Kathy Smolenski; Susan M Staugaitis; Ruth Steele; Leigh Thorne; Daniela P C Tirapelli; Andreas Unterberg; Mahitha Vallurupalli; Yun Wang; Ronald Warnick; Felicia Williams; Yingli Wolinsky; Sue Bell; Mara Rosenberg; Chip Stewart; Franklin Huang; Jonna L Grimsby; Amie J Radenbaugh; Jianan Zhang
Journal:  N Engl J Med       Date:  2015-06-10       Impact factor: 91.245

2.  Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study.

Authors:  Whitney B Pope; Xin Joe Qiao; Hyun J Kim; Albert Lai; Phioanh Nghiemphu; Xi Xue; Benjamin M Ellingson; David Schiff; Dawit Aregawi; Soonmee Cha; Vinay K Puduvalli; Jing Wu; Wai-Kwan A Yung; Geoffrey S Young; James Vredenburgh; Dan Barboriak; Lauren E Abrey; Tom Mikkelsen; Rajan Jain; Nina A Paleologos; Patricia Lada; Michael Prados; Jonathan Goldin; Patrick Y Wen; Timothy Cloughesy
Journal:  J Neurooncol       Date:  2012-03-18       Impact factor: 4.130

3.  Differentiation of tumor progression from pseudoprogression in patients with posttreatment glioblastoma using multiparametric histogram analysis.

Authors:  J Cha; S T Kim; H-J Kim; B-J Kim; Y K Kim; J Y Lee; P Jeon; K H Kim; D-S Kong; D-H Nam
Journal:  AJNR Am J Neuroradiol       Date:  2014-03-27       Impact factor: 3.825

4.  Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma.

Authors:  Jinhua Yu; Zhifeng Shi; Yuxi Lian; Zeju Li; Tongtong Liu; Yuan Gao; Yuanyuan Wang; Liang Chen; Ying Mao
Journal:  Eur Radiol       Date:  2016-12-21       Impact factor: 5.315

5.  Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response.

Authors:  Philipp Kickingereder; Michael Götz; John Muschelli; Antje Wick; Ulf Neuberger; Russell T Shinohara; Martin Sill; Martha Nowosielski; Heinz-Peter Schlemmer; Alexander Radbruch; Wolfgang Wick; Martin Bendszus; Klaus H Maier-Hein; David Bonekamp
Journal:  Clin Cancer Res       Date:  2016-10-10       Impact factor: 12.531

Review 6.  Molecular diagnostics of gliomas: state of the art.

Authors:  Markus J Riemenschneider; Judith W M Jeuken; Pieter Wesseling; Guido Reifenberger
Journal:  Acta Neuropathol       Date:  2010-08-17       Impact factor: 17.088

7.  Normalization of ADC does not improve correlation with overall survival in patients with high-grade glioma (HGG).

Authors:  Lei Qin; Angie Li; Jinrong Qu; Katherine Reinshagen; Xiang Li; Su-Chun Cheng; Annie Bryant; Geoffrey S Young
Journal:  J Neurooncol       Date:  2018-01-30       Impact factor: 4.130

8.  Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery.

Authors:  Amir Zolal; Tareq A Juratli; Jennifer Linn; Dino Podlesek; Kerim Hakan Sitoci Ficici; Hagen H Kitzler; Gabriele Schackert; Stephan B Sobottka; Bernhard Rieger; Dietmar Krex
Journal:  J Neurooncol       Date:  2016-01-30       Impact factor: 4.130

9.  Adult IDH wild-type lower-grade gliomas should be further stratified.

Authors:  Abudumijit Aibaidula; Aden Ka-Yin Chan; Zhifeng Shi; Yanxi Li; Ruiqi Zhang; Rui Yang; Kay Ka-Wai Li; Nellie Yuk-Fei Chung; Yu Yao; Liangfu Zhou; Jinsong Wu; Hong Chen; Ho-Keung Ng
Journal:  Neuro Oncol       Date:  2017-10-01       Impact factor: 12.300

10.  Diffusion tensor image features predict IDH genotype in newly diagnosed WHO grade II/III gliomas.

Authors:  Paul Eichinger; Esther Alberts; Claire Delbridge; Stefano Trebeschi; Alexander Valentinitsch; Stefanie Bette; Thomas Huber; Jens Gempt; Bernhard Meyer; Juergen Schlegel; Claus Zimmer; Jan S Kirschke; Bjoern H Menze; Benedikt Wiestler
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

View more
  9 in total

Review 1.  A Survey of Radiomics in Precision Diagnosis and Treatment of Adult Gliomas.

Authors:  Peng Du; Hongyi Chen; Kun Lv; Daoying Geng
Journal:  J Clin Med       Date:  2022-06-30       Impact factor: 4.964

Review 2.  Preoperative Diagnosis and Molecular Characterization of Gliomas With Liquid Biopsy and Radiogenomics.

Authors:  Carmen Balana; Sara Castañer; Cristina Carrato; Teresa Moran; Assumpció Lopez-Paradís; Marta Domenech; Ainhoa Hernandez; Josep Puig
Journal:  Front Neurol       Date:  2022-05-26       Impact factor: 4.086

Review 3.  The progress of multimodal imaging combination and subregion based radiomics research of cancers.

Authors:  Luyuan Zhang; Yumin Wang; Zhouying Peng; Yuxiang Weng; Zebin Fang; Feng Xiao; Chao Zhang; Zuoxu Fan; Kaiyuan Huang; Yu Zhu; Weihong Jiang; Jian Shen; Renya Zhan
Journal:  Int J Biol Sci       Date:  2022-05-09       Impact factor: 10.750

4.  Radiomics features of hippocampal regions in magnetic resonance imaging can differentiate medial temporal lobe epilepsy patients from healthy controls.

Authors:  Yae Won Park; Yun Seo Choi; Song E Kim; Dongmin Choi; Kyunghwa Han; Hwiyoung Kim; Sung Soo Ahn; Sol-Ah Kim; Hyeon Jin Kim; Seung-Koo Lee; Hyang Woon Lee
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379

5.  A Radiomics Model for Predicting Early Recurrence in Grade II Gliomas Based on Preoperative Multiparametric Magnetic Resonance Imaging.

Authors:  Zhen-Hua Wang; Xin-Lan Xiao; Zhao-Tao Zhang; Keng He; Feng Hu
Journal:  Front Oncol       Date:  2021-09-02       Impact factor: 6.244

6.  Noninvasive Determination of IDH and 1p19q Status of Lower-grade Gliomas Using MRI Radiomics: A Systematic Review.

Authors:  A P Bhandari; R Liong; J Koppen; S V Murthy; A Lasocki
Journal:  AJNR Am J Neuroradiol       Date:  2020-11-26       Impact factor: 3.825

Review 7.  Accuracy of Machine Learning Algorithms for the Classification of Molecular Features of Gliomas on MRI: A Systematic Literature Review and Meta-Analysis.

Authors:  Evi J van Kempen; Max Post; Manoj Mannil; Benno Kusters; Mark Ter Laan; Frederick J A Meijer; Dylan J H A Henssen
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

8.  Comparison of Diagnostic Performance of Two-Dimensional and Three-Dimensional Fractal Dimension and Lacunarity Analyses for Predicting the Meningioma Grade.

Authors:  Soopil Kim; Yae Won Park; Sang Hyun Park; Sung Soo Ahn; Jong Hee Chang; Se Hoon Kim; Seung Koo Lee
Journal:  Brain Tumor Res Treat       Date:  2020-04

9.  Differentiating mass-like tuberculosis from lung cancer based on radiomics and CT features.

Authors:  Shuhua Wei; Bin Shi; Jinmei Zhang; Naiyu Li
Journal:  Transl Cancer Res       Date:  2021-10       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.